Brentuximab Vedotin in Advanced Hodgkin's Lymphoma. Reply
- PMID: 36260801
- DOI: 10.1056/NEJMc2211125
Brentuximab Vedotin in Advanced Hodgkin's Lymphoma. Reply
Comment on
-
Brentuximab Vedotin in Advanced Hodgkin's Lymphoma.N Engl J Med. 2022 Oct 20;387(16):1527. doi: 10.1056/NEJMc2211125. N Engl J Med. 2022. PMID: 36260800 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical